Adalimumab-adaz Injection shortage
To Be Discontinued 5 presentations · 1 manufacturers · first FDA posting Jan 13, 2026 · last update Jan 13, 2026
Manufacturers: Sandoz Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36) | Sandoz Inc. | To Be Discontinued | — | Equivalent Sandoz format is available. | Posted Jan 13, 2026 Updated Jan 13, 2026 Discontinued Jan 13, 2026 |
| Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68) | Sandoz Inc. | To Be Discontinued | — | Equivalent Sandoz format is available. | Posted Jan 13, 2026 Updated Jan 13, 2026 Discontinued Jan 13, 2026 |
| Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64) | Sandoz Inc. | To Be Discontinued | — | Equivalent Sandoz format is available. | Posted Jan 13, 2026 Updated Jan 13, 2026 Discontinued Jan 13, 2026 |
| Hyrimoz, Injection, Kit (NDC 61314-517-36) | Sandoz Inc. | To Be Discontinued | — | Equivalent Sandoz format is available. | Posted Jan 13, 2026 Updated Jan 13, 2026 Discontinued Jan 13, 2026 |
| Hyrimoz, Injection, Kit (NDC 61314-531-64) | Sandoz Inc. | To Be Discontinued | — | Equivalent Sandoz format is available. | Posted Jan 13, 2026 Updated Jan 13, 2026 Discontinued Jan 13, 2026 |